Arbutus Biopharma
ABUS
#6404
Rank
S$0.82 B
Marketcap
$4.36
Share price
0.00%
Change (1 day)
38.69%
Change (1 year)

Earnings for Arbutus Biopharma (ABUS)

Earnings in 2024 (TTM): -S$0.11 Billion

According to Arbutus Biopharma 's latest financial reports the company's current earnings are S$6.74 Million. In 2023 the company made an earning of -S$98.84 Million a decrease over its 2022 earnings that were of -S$88.21 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arbutus Biopharma from 2008 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$0.11 Billion2.92%
2023 -S$98.84 Million12.05%
2022 -S$88.21 Million-14.74%
2021 -S$0.11 Billion19.61%
2020 -S$86.49 Million-61.69%
2019 -S$0.23 Billion171.23%
2018 -S$83.23 Million-43.58%
2017 -S$0.15 Billion-77.77%
2016 -S$0.67 Billion532.77%
2015 -S$0.11 Billion99.05%
2014 -S$52.7 Million175.82%
2013 -S$19.11 Million-143.7%
2012 S$43.71 M-399.11%
2011 -S$14.62 Million-39.03%
2010 -S$23.98 Million100.55%
2009 -S$11.96 Million-28.56%
2008 -S$16.74 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
S$50.76 M-148.78%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$2.94 Million-97.18% Bahamas